Shaping the T-cell repertoire: A matter of life and death

Immunology and Cell Biology

Volumn 89, Issue 1, 2011, Pages 33-39

  Wiegers, G Jan ^a   Kaufmann, Manuel ^a   Tischner, Denise ^a   Villunger, Andreas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

apoptosis; Bcl 2 family; BH3 only proteins; glucocorticoids; thymocytes; tolerance

Indexed keywords

CYTOKINE; GLUCOCORTICOID; PROTEIN BCL 2; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; APOPTOSIS; CELL DEATH; CELL SELECTION; CELL SURVIVAL; CLONAL VARIATION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CLONAL DELETION; GLUCOCORTICOIDS; HUMANS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THYMUS GLAND;

EID: 78651085350     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.127     Document Type: Review

References (71)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
2. Lu LF, Rudensky A. Molecular orchestration of differentiation and function of regulatory T cells. Genes Dev 2009; 23: 1270-1282.
3. Kyewski B, Klein L. A central role for central tolerance. Annu Rev Immunol 2006; 24: 571-606.
4. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002; 298: 1395-1401.
5. Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997; 17: 399-403.
6. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M et al. Positional cloning of the APECED gene. Nat Genet 1997; 17: 393-398.
7. Chen Z, Benoist C, Mathis D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci USA 2005; 102: 14735-14740.
8. Strasser A. The role of BH3-only proteins in the immune system. Nat Rev Immunol 2005; 5: 189-200.
9. Tischner D, Woess C, Ottina E, Villunger A. Bcl-2-regulated cell death signalling in the prevention of autoimmunity. Cell Death Dis 2010; 1, e48; doi:10.1038/cddis.2010.27.
10. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47-59.
11. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
12. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76: 969-976.
13. Rieux-Laucat F, Le DF, Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ 2003; 10: 124-133.
14. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Köntgen F et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999; 286: 1735-1738.
15. Oliveira JB, Bidere N, Niemela JE, Zheng L, Sakai K, Nix CP et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci USA 2007; 104: 8953-8958.
16. Klein L, Hinterberger M, Wirnsberger G, Kyewski B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol 2009; 9: 833-844.
17. Rathmell JC, Lindsten T, ZongWX, Cinalli RM, Thompson CB. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol 2002; 3: 932-939.
18. Erlacher M, Labi V, Manzl C, Böck G, Tzankov A, Häcker G et al. Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J Exp Med 2006; 203: 2939-2951.
19. Hutcheson J, Perlman H. Loss of Bim results in abnormal accumulation of mature CD4- CD8-CD44-CD25- thymocytes. Immunobiology 2007; 212: 629-636.
20. Berzins SP, Godfrey DI, Miller JF, Boyd RL. A central role for thymic emigrants in peripheral T cell homeostasis. Proc Natl Acad Sci USA 1999; 96: 9787-9791.
21. Gossens K, Naus S, Corbel SY, Lin S, Rossi FM, Kast J et al. Thymic progenitor homing and lymphocyte homeostasis are linked via S1P-controlled expression of thymic Pselectin/ CCL25. J Exp Med 2009; 206: 761-778.
22. Chambers CA, Cado D, Truong T, Allison JP. Thymocyte development is normal in CTLA- 4-deficient mice. Proc Natl Acad Sci USA 1997; 94: 9296-9301.
23. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995; 3: 521-530.
24. Cohen JJ. Glucocorticoid-induced apoptosis in the thymus. Semin Immunol 1992; 4: 363-369.
25. Erlacher M, Knoflach M, Stec IE, Bock G, Wick G, Wiegers GJ. TCR signaling inhibits glucocorticoid-induced apoptosis in murine thymocytes depending on the stage of development. Eur J Immunol 2005; 35: 3287-3296.
26. Compton MM, Cidlowski JA. Rapid in vivo effects of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid. Endocrinology 1986; 118: 38-45.
27. + thymocytes in vivo by anti-CD3 or 5¢-(N-ethyl)-carboxamide adenosine is blocked by glucocorticoid receptor antagonist RU-486. Eur J Immunol 1993; 23: 1246-1250.
28. Gruber J, Sgonc R, Hu YH, Beug H, Wick G. Thymocyte apoptosis induced by elevated endogenous corticosterone levels. Eur J Immunol 1994; 24: 1115-1121.
29. Jaffe HL. The influence of the suprarenal gland on the thymus: iii. Stimulation of the growth of the thymus gland following double suprarenalectomy in young rats. J ExpMed 1924; 40: 753-759.
30. Pruett SB, Padgett EL. Thymus-derived glucocorticoids are insufficient for normal thymus homeostasis in the adult mouse. BMC Immunol 2004; 5: 24.
31. King LB, Vacchio MS, Dixon K, Hunziker R, Margulies DH, Ashwell JD. A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity 1995; 3: 647-656.
32. Lu FW, Yasutomo K, Goodman GB, McHeyzer-Williams LJ, McHeyzer-Williams MG, Germain RN et al. Thymocyte resistance to glucocorticoids leads to antigen-specific unresponsiveness due to holes in the T cell repertoire. Immunity 2000; 12: 183-192.
33. Pazirandeh A, Xue Y, Prestegaard T, Jondal M, Okret S. Effects of altered glucocorticoid sensitivity in the T cell lineage on thymocyte and T cell homeostasis. FASEB J 2002; 16: 727-729.
34. Purton JF, Boyd RL, Cole TJ, Godfrey DI. Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling. Immunity 2000; 13: 179-186.
35. Purton JF, Zhan Y, Liddicoat DR, Hardy CL, Lew AM, Cole TJ et al. Glucocorticoid receptor deficient thymic and peripheral T cells develop normally in adult mice. Eur J Immunol 2002; 32: 3546-3555.
36. Mittelstadt PR, Ashwell JD. Disruption of glucocorticoid receptor exon 2 yields a ligandresponsive C-terminal fragment that regulates gene expression. Mol Endocrinol 2003; 17: 1534-1542.
37. Brewer JA, Kanagawa O, Sleckman BP, Muglia LJ. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J Immunol 2002; 169: 1837-1843.
38. Brewer JA, Khor B, Vogt SK, Muglia LM, Fujiwara H, Haegele KE et al. T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation. Nat Med 2003; 9: 1318-1322.
39. Baumann S, Dostert A, Novac N, Bauer A, Schmid W, Fas SC et al. Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer. Blood 2005; 106: 617-625.
40. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998; 93: 531-541.
41. Vacchio MS, Papadopoulos V, Ashwell JD. Steroid production in the thymus: implications for thymocyte selection. J Exp Med 1994; 179: 1835-1846.
42. Pazirandeh A, Xue Y, Rafter I, Sjovall J, Jondal M, Okret S. Paracrine glucocorticoid activity produced by mouse thymic epithelial cells. FASEB J 1999; 13: 893-901.
43. Jenkinson EJ, Parnell S, Shuttleworth J, Owen JJ, Anderson G. Specialized ability of thymic epithelial cells to mediate positive selection does not require expression of the steroidogenic enzyme p450scc. J Immunol 1999; 163: 5781-5785.
44. Lechner O, Wiegers GJ, Oliveira-Dos-Santos AJ, Dietrich H, Recheis H, Waterman M et al. Glucocorticoid production in the murine thymus. Eur J Immunol 2000; 30: 337-346.
45. Qiao S, Chen L, Okret S, Jondal M. Age-related synthesis of glucocorticoids in thymocytes. Exp Cell Res 2008; 314: 3027-3035.
46. Pazirandeh A, Jondal M, Okret S. Conditional expression of a glucocorticoid receptor transgene in thymocytes reveals a role for thymic-derived glucocorticoids in thymopoiesis in vivo. Endocrinology 2005; 146: 2501-2507.
47. Qiao S, Okret S, Jondal M. Thymocyte-synthesized glucocorticoids play a role in thymocyte homeostasis and are down-regulated by adrenocorticotropic hormone. Endocrinology 2009; 150: 4163-4169.
48. Chen Y, Qiao S, Tuckermann J, Okret S, Jondal M. Thymus-derived glucocorticoids mediate androgen effects on thymocyte homeostasis. FASEB J 2010 (e-pub ahead of print 26 August 2010; doi:10.1096/fj.10-168724).
49. Sutherland JS, Goldberg GL, Hammett MV, Uldrich AP, Berzins SP, Heng TS et al. Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol 2005; 175: 2741-2753.
50. Erlacher M, Michalak EM, Kelly PN, Labi V, Niederegger H, Coultas L et al. BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 2005; 106: 4131-4138.
51. Mathis D, Benoist C. Aire. Annu Rev Immunol 2009; 27: 287-312.
52. Thien CB, Blystad FD, Zhan Y, Lew AM, Voigt V, Andoniou CE et al. Loss of c-Cbl RING finger function results in high-intensity TCR signaling and thymic deletion. EMBO J 2005; 24: 3807-3819.
53. Thien CB, Dagger SA, Steer JH, Koentgen F, Jansen ES, Scott CL et al. c-Cbl promotes T cell receptor-induced thymocyte apoptosis by activating the phosphatidylinositol 3- kinase/Akt pathway. J Biol Chem 2010; 285: 10969-10981.
54. McCarty N, Paust S, Ikizawa K, Dan I, Li X, Cantor H. Signaling by the kinase MINK is essential in the negative selection of autoreactive thymocytes. Nat Immunol 2005; 6: 65-72.
55. Sohn SJ, Rajpal A, Winoto A. Apoptosis during lymphoid development. Curr Opin Immunol 2003; 15: 209-216.
56. Pinon JD, Labi V, Egle A, Villunger A. Bim and Bmf in tissue homeostasis and malignant disease. Oncogene 2008; 27(Suppl 1): S41-S52.
57. Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, Puthalakath H et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002; 415: 922-926.
58. Villunger A, Marsden VS, Zhan Y, Erlacher M, Lew AM, Bouillet P et al. Negative selection of semimature CD4(+)8(-)HSA+ thymocytes requires the BH3-only protein Bim but is independent of death receptor signaling. Proc Natl Acad Sci USA 2004; 101: 7052-7057.
59. Liston A, Lesage S, Gray DH, OReilly LA, Strasser A, Fahrer AM et al. Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 2004; 21: 817-830.
60. Bouillet P, Cory S, Zhang LC, Strasser A, Adams JM. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell 2001; 1: 645-653.
61. Ludwinski MW, Sun J, Hilliard B, Gong S, Xue F, Carmody RJ et al. Critical roles of Bim in T cell activation and T cell-mediated autoimmune inflammation in mice. J Clin Invest 2009; 119: 1706-1713.
62. Hu Q, Sader A, Parkman JC, Baldwin TA. Bim-mediated apoptosis is not necessary for thymic negative selection to ubiquitous self-antigens. J Immunol 2009; 183: 7761-7767.
63. Kovalovsky D, Pezzano M, Ortiz BD, Santangelo DB. A novel TCR transgenic model reveals that negative selection involves an immediate, Bim-dependent pathway and a delayed, Bim-independent pathway. PLoS One 2010; 5: e8675.
64. Thompson J, Winoto A. During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain. J Exp Med 2008; 205: 1029-1036.
65. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991; 67: 879-888.
66. Zehn D, Lee SY, Bevan MJ. Complete but curtailed T-cell response to very low-affinity antigen. Nature 2009; 458: 211-214.
67. Wensveen FM, van Gisbergen KP, Derks IA, Gerlach C, Schumacher TN, van Lier RA et al. Apoptosis threshold set by Noxa and Mcl-1 after T cell activation regulates competitive selection of high-affinity clones. Immunity 2010; 32: 754-765.
68. Ploner C, Kofler R, Villunger A. Noxa: at the tip of the balance between life and death. Oncogene 2008; 27(Suppl 1): S84-S92.
69. Villunger A. Only the strong survive. Immunity 2010; 32: 729-731.
70. Bardwell PD, Gu J, McCarthy D, Wallace C, Bryant S, Goess C et al. The Bcl-2 family antagonist ABT-737 significantly inhibits multiple animal models of autoimmunity. J Immunol 2009; 182: 7482-7489.
71. Scatizzi JC, Hutcheson J, Pope RM, Firestein GS, Koch AE, Mavers M et al. Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis. Arthritis Rheum 2010; 62: 441-451.